The CAIRE membership represents over 140 researchers and stakeholders from more than 30 institutions across Canada. Membership includes most of the “translational” vaccine experts involved in vaccine and program development, evaluation and training.
Membership provides an opportunity to share, connect, and collaborate within Canada for evaluation of new vaccines, building the rationale for new public programs and optimizing public immunization programs.
Global Strategies for Global Impact
4th-6th November, 2015
The 2015 International Neonatal & Maternal Immunisation Symposium (INMIS) will be held in The Gabmia, West Africa from November 4-6, 2015. Over the last few years, a number of clinical trials have enrolled mothers and infants into vaccine studies, including in Africa. This next INMIS will assess the lessons learned from these and other ongoing international trials, to discuss current scientific progress in maternal and neonatal immunology, infections and immunisations, in the broader context of infectious disease epidemiology and public health.
This year 22 students applied for the Vaccinology Student Research Program (VSRP) at the Canadian Immunization Conference (CIC), almost double from previous years. Five students received travel bursaries to attend the conference with all student applicants invited to participate in the Student Poster Presentation. CAIRE and CIHR have co-funded the VSRP.
Congratulations to all students for a job well done! (pictures below)
Following each plenary session, the plenary speaker will host a dedicated Q&A with webcast participants for 15 minutes. Here’s how: Submit your question on the live stream website Email your question to email@example.com Ask your question on Twitter using #CIC2014
CAIRE and the Meningitis Foundation of Canada hosted a Research Round Table on April 3rd, 2014. The webcast was recorded which provides an opportunity for individuals from all over Canada to watch and participate. Speakers presented on the global lessons learned from Meningococcal C vaccine programs and factors for decision-makers to consider for the implementation of Meningococcal B vaccine programs, the epidemiology, safety surveillance capacity, vaccine acceptance issues and economic modelling related to Meningococcal disease in Canada. Speakers and participants identified research priorities prior, during and after the presentations. Analysis and presentation of the results of these ranked research priorities have yet to be distributed and/or published.
In addition, Dr. Andrew Pollard presented a second talk on Meningococcal Disease on Friday, April 4, 2014 at the BC Children’s Hospital Grand Rounds. Click here, to view this talk
Career opportunities, such as training and higher management positions, or funding announcements may be submitted to CAIRE and posted in this space.
Complete this job description form to have your career opportunity or funding announcement posted.